King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Nour Almozain
Dr. Nour Almozain is a Consultant Hematopathologist in Riyadh, Saudi Arabia, specialising in the diagnosis of haematological malignancies and transfusion / cellular-therapy medicine. A trusted best hematopathology doctor in India and the Middle East, she co-authored international consensus recommendations on quality indicators for immune effector cell and gene-therapy collections — providing expert diagnostic support to the CAR-T and stem-cell transplantation programmes.Consultant in the Hematopathology & Transfusion Medicine Section, Department of Pathology and Laboratory Medicine, at a national cancer programme.Co-author on international consensus recommendations for immune effector cell / gene therapy collection quality.Co-author on a multicentre Saudi myelodysplastic syndrome spectrum study.Provides integrated flow cytometry, cytogenetics, and molecular diagnostic support to the adult and paediatric haematology services.Experienced in international patient slide review and second-opinion hematopathology.Qualifications & Credentials
Medical Degrees
- MBBS
Fellowships & Special Training
- Residency — Anatomic & Clinical Pathology
- Fellowship — Hematopathology
- Advanced training — Transfusion Medicine & Apheresis / Cellular Therapy
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) Registration
- Member — Society for Hematopathology (SH)
- Member — American Society for Apheresis (ASFA)
- Member — American Society of Hematology (ASH)
- Member — Association for the Advancement of Blood & Biotherapies (AABB)
Areas of Expertise
Major Conditions Treated
- Acute Lymphoblastic Leukemia (B-ALL, T-ALL) — Diagnostic Workup
- Acute Myeloid Leukemia (AML) — Classification
- Chronic Myeloid Leukemia (CML)
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Neoplasms (MPN)
- Mature B-cell & T-cell Lymphomas
- Plasma Cell Neoplasms (Multiple Myeloma, MGUS)
- Bone Marrow Failure Syndromes
- Haemoglobinopathies (Sickle Cell, Thalassemia — Lab Workup)
- CAR-T & Gene-Therapy Cell Collection Quality
- Transfusion-Related Complications
Sub-specialties
- Diagnostic Hematopathology: Integrated morphology, immunohistochemistry, flow cytometry, and molecular / cytogenetic correlation for haematological malignancies — a trusted hematopathology specialist Riyadh, Saudi Arabia providing best slide-review and second-opinion hematopathology in India and the region.
- Transfusion Medicine & Cellular Therapy: Blood bank medical direction, apheresis, HLA-antibody workup, platelet refractoriness management, and quality oversight of stem-cell and immune effector cell collections for HSCT and CAR-T programmes.
- Flow Cytometry & MRD: Diagnostic and minimal residual disease (MRD) flow cytometry for acute leukaemia, CLL, and plasma-cell neoplasms — guiding therapy decisions in adult and paediatric patients.
Advanced Procedures & Treatments
- Bone Marrow Aspirate / Biopsy Interpretation
- Peripheral Blood Smear Review
- Immunohistochemistry (CD / TdT / MPO / PAX5 / CD138 etc.)
- Multiparameter Flow Cytometry (Diagnostic & MRD)
- FISH / Karyotyping Correlation
- Molecular Diagnostics (BCR-ABL1, JAK2, FLT3, NPM1, IDH1/2, CEBPA)
- Hemoglobin Electrophoresis & HPLC
- Transfusion & Blood Bank Medical Direction
- Apheresis & Cellular Therapy Collection Quality
Professional Experience
Current Affiliation
- Consultant Hematopathologist — Hematopathology & Transfusion Medicine, Department of Pathology & Laboratory Medicine, King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia (Present)
Past Affiliations
- King Saud University Medical City, Riyadh, Saudi Arabia — Department of Pathology, Hematology Section (Past)
- King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia — Department of Pathology (Earlier)
Academic & Research Roles
- Co-author — international consensus recommendations for immune effector cell / gene therapy collection quality
- Participant — multidisciplinary hematology and lymphoma tumour boards
Key Achievements
- Co-author on international consensus recommendations for CAR-T / gene-therapy cell-collection quality
- Co-author on a multicentre Saudi myelodysplastic syndrome spectrum study
- Provides diagnostic support to CAR-T, allogeneic and autologous HSCT programmes
- Active in international transfusion-medicine and cellular-therapy research networks
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- Society for Hematopathology (SH)
- American Society for Apheresis (ASFA)
- American Society of Hematology (ASH)
- Association for the Advancement of Blood & Biotherapies (AABB)
Research & Publications
Published Papers (Selected)
- Co-author on American Society for Apheresis consensus recommendations for quality indicators in immune effector cell and gene therapy collections.
- First author on a multicentre Saudi report on the spectrum of myelodysplastic syndrome in patients evaluated for cytopenias.
- Case report on Hunter syndrome and Alder-Reilly anomaly.
- Research on discrepancies between DNA index by flow cytometry and cytogenetic studies in childhood B-lymphoblastic leukaemia.
Ongoing Research & Clinical Interests
- Quality indicators for CAR-T and gene-therapy cell collections
- Myelodysplastic syndrome epidemiology in Saudi Arabia
- Flow cytometry and molecular diagnostics in acute leukaemia
- Haematological manifestations of inherited metabolic disorders
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Hematopathology Consultation / Slide Review | ₹2,000 – ₹5,000 | $24 – $60 |
| Peripheral Blood Smear Review | ₹800 – ₹2,500 | $10 – $30 |
| Bone Marrow Biopsy — Histopathology Reporting | ₹8,000 – ₹20,000 | $96 – $240 |
| Flow Cytometry / Immunophenotyping Panel | ₹15,000 – ₹45,000 | $180 – $540 |
| Molecular / Cytogenetic Panel (FISH, PCR, NGS) | ₹20,000 – ₹90,000 | $240 – $1,080 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Nour Almozain use in Hematopathology & Transfusion Medicine treatment?
Dr. Nour Almozain uses an integrated diagnostic toolkit — bone marrow morphology, immunohistochemistry, multiparameter flow cytometry (including minimal residual disease), cytogenetics / FISH correlation, and molecular diagnostics (BCR-ABL1, JAK2, FLT3, NPM1, IDH1/2) — plus transfusion-medicine and apheresis expertise for CAR-T and HSCT cell collection quality. Second-opinion slide review can be arranged for international patients through Cancer Rounds.
2. What conditions does Dr. Nour Almozain specialize in treating?
Dr. Nour Almozain specialises in the diagnostic workup of haematological malignancies — acute lymphoblastic and myeloid leukaemias, chronic myeloid leukaemia, myelodysplastic syndromes, myeloproliferative neoplasms, mature B- and T-cell lymphomas, plasma cell neoplasms (multiple myeloma), and bone marrow failure syndromes — plus transfusion medicine and cellular therapy collection quality, making her a trusted best hematopathology doctor India and Middle East in Riyadh, Saudi Arabia.
3. How do I book an appointment with Dr. Nour Almozain?
Appointments with Dr. Nour Almozain can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Nour Almozain?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Nour Almozain, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Nour Almozain offer second opinions for Hematopathology & Transfusion Medicine cases?
Yes. Second-opinion consultations with Dr. Nour Almozain can be arranged via Cancer Rounds for patients who wish to have their bone marrow / blood smear / flow cytometry / molecular diagnostic results re-reviewed by an expert Hematopathology and Transfusion Medicine specialist in Riyadh, Saudi Arabia.
